Locana is developing
a portfolio of RNA-targeting gene therapies
A flexible means to precisely treat
a range of human genetic diseases
Locana has a versatile platform technology with the potential to correct the underlying causes of human genetic disease.
Locana is actively engaged in partnering discussions to extend the capabilities of our platform, facilitate rapid advancement of our internal pipeline programs, and expand into additional disease areas.
Please contact email@example.com regarding any business development opportunities.